当前位置: 首页 > 期刊 > 《世界中医药》 > 2021年第19期
编号:215648
交泰丸治疗2型糖尿病的研究进展
http://www.100md.com 2021年12月16日 世界中医药 2021年第19期
黄连,降糖,胰岛
     王志 苏浩 唐悦恒 聂可馨 王宏展 高洋 董慧 陆付耳 黄文雅

    摘要 糖尿病的患病人数逐年增加,不仅严重威胁人类健康,也给社会和家庭带来了沉重的经济负担。口服降糖药和胰岛素等治疗糖尿病的药物,能部分缓解胰岛素分泌缺陷和胰岛素抵抗等问题,但不良反应明显。中医药治疗糖尿病及其并发症历史悠久,应用前景广阔。其中,交泰丸治疗2型糖尿病(T2DM)受到越来越多的关注。现对交泰丸治疗T2DM的研究进展进行综述。

    关键词 2型糖尿病;交泰丸;小檗碱;胰岛素抵抗;抗炎;B细胞;脂质代谢

    Abstract The prevalence of diabetes is increasing year by year,which is not only a threat to human health,but also brings heavy financial burden to society and families.Oral antidiabetic drugs,insulin and other anti-diabetic drugs partly alleviate the problems of insulin secretion defects and insulin resistance,but side effects arepointed.Chinese medicine has a long history of treating diabetes and its complications,with great application prospects.The treatment of type 2 diabetes mellitus(T2DM) by Jiaotai pill has attracted more and more attention.This article will review the research progress of the treatment of T2DM with Jiaotai pill.

    Keywords Type 2 diabetes mellitus; Jiaotai pill; Berberine; Insulin resistance; Anti-inflammatory; B cells; Lipid metabolism

    中图分类号:R587.1文献标识码:Adoi:10.3969/j.issn.1673-7202.2021.19.001

    国际糖尿病联盟(The International Diabetes Federation ......

您现在查看是摘要页,全文长 22331 字符